Literature DB >> 21107260

The global burden of cataract.

Gullapalli N Rao1, Rohit Khanna, Abhishek Payal.   

Abstract

PURPOSE OF REVIEW: To review the previous year's literature related to prevalence of blindness in general, blindness due to cataract, cataract surgical coverage (CSC) and cataract surgical rates (CSRs). RECENT
FINDINGS: Cataracts are the major cause of blindness and visual impairment in developing countries and contributes to more than 90% of the total disability adjusted life years. This review shows that coverage continues to be a problem in many countries, especially for the female population, those residing in rural areas and those who are illiterate. Although CSR is an indicator of the availability and acceptability of services, for measuring the impact of the program, we should look at combining CSR with CSC. This strategy would also enable us achieve our goal of eliminating avoidable blindness due to cataracts by the year 2020.
SUMMARY: Cataracts still continue- to be a major cause of blindness globally and with the rapidly aging population, it is a challenge to tackle. We need to plan a comprehensive strategy addressing issues related to availability, affordability, accessibility and acceptability of eye-care services.

Entities:  

Mesh:

Year:  2011        PMID: 21107260     DOI: 10.1097/ICU.0b013e3283414fc8

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  60 in total

1.  Implication of the miR-184 and miR-204 competitive RNA network in control of mouse secondary cataract.

Authors:  Andrea Hoffmann; Yusen Huang; Rinako Suetsugu-Maki; Carol S Ringelberg; Craig R Tomlinson; Katia Del Rio-Tsonis; Panagiotis A Tsonis
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

2.  Compound mouse mutants of bZIP transcription factors Mafg and Mafk reveal a regulatory network of non-crystallin genes associated with cataract.

Authors:  Smriti A Agrawal; Deepti Anand; Archana D Siddam; Atul Kakrana; Soma Dash; David A Scheiblin; Christine A Dang; Anne M Terrell; Stephanie M Waters; Abhyudai Singh; Hozumi Motohashi; Masayuki Yamamoto; Salil A Lachke
Journal:  Hum Genet       Date:  2015-04-21       Impact factor: 4.132

Review 3.  Biophysical chemistry of the ageing eye lens.

Authors:  Nicholas J Ray
Journal:  Biophys Rev       Date:  2015-08-23

4.  Relationship between socioeconomic and lifestyle factors and cataracts in Koreans: the Korea National Health and Nutrition Examination Survey 2008-2011.

Authors:  G E Nam; K Han; S G Ha; B-D Han; D H Kim; Y-H Kim; K H Cho; Y G Park; B-J Ko
Journal:  Eye (Lond)       Date:  2015-05-15       Impact factor: 3.775

Review 5.  Tripping up Trp: Modification of protein tryptophan residues by reactive oxygen species, modes of detection, and biological consequences.

Authors:  Marilyn Ehrenshaft; Leesa J Deterding; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2015-09-21       Impact factor: 7.376

Review 6.  Aging and age-related diseases of the ocular lens and vitreous body.

Authors:  J Mark Petrash
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-13       Impact factor: 4.799

7.  Hypericin-mediated photooxidative damage of α-crystallin in human lens epithelial cells.

Authors:  Marilyn Ehrenshaft; Joan E Roberts; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2013-02-27       Impact factor: 7.376

Review 8.  Clinical Applications of Dexamethasone for Aged Eyes.

Authors:  Beatriz Abadia; Pilar Calvo; Antonio Ferreras; Fran Bartol; Guayente Verdes; Luis Pablo
Journal:  Drugs Aging       Date:  2016-09       Impact factor: 3.923

9.  Association of Sex With the Global Burden of Cataract.

Authors:  Lixia Lou; Xin Ye; Peifang Xu; Jingyi Wang; Yufeng Xu; Kai Jin; Juan Ye
Journal:  JAMA Ophthalmol       Date:  2018-02-01       Impact factor: 7.389

10.  Prevalence and risk factors for eye diseases, blindness, and low vision in Lhasa, Tibet.

Authors:  Gui-Qin Wang; Zong-Xi Bai; Jing Shi; Sang Luo; Hong-Fa Chang; Xiao-Yong Sai
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.